Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Indicators of amyloid burden in a population-based study of cognitively normal elderly.

Neurology - 9 Oct 2012

Mielke Michelle M, Wiste Heather J, Weigand Stephen D, Knopman David S, Lowe Val J, Roberts Rosebud O, Geda Yonas E, Swenson-Dravis Dana M, Boeve Bradley F, Senjem Matthew L, Vemuri Prashanthi, Petersen Ronald C, Jack Clifford R

Abstract excerpt

OBJECTIVES: Secondary prevention trials in subjects with preclinical Alzheimer disease may require documentation of brain amyloidosis. The identification of inexpensive and noninvasive screening variables that can identify individuals who have significant amyloid accumulation would reduce screening costs. METHODS: A total of 483 cognitively normal (CN) individuals, aged 70-92 years, from the population-based Mayo...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Amyloid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Apolipoproteins E

Share to Brain Mapping

Share to Cognition

Share to Neuropsychological Tests

Share to Radionuclide Imaging

Source

Open in PubMed Open full text

Identifiers

PMID: 22972644
DOI: 10.1212/WNL.0b013e31826e2696
PMCID: PMC3475629

Genes

APOE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Indicators of amyloid burden in a population-based study of cognitively normal elderly.PMID 22972644Read ↗

Predicting amyloid beta accumulation in cognitively unimpaired older adults: Cognitive assessments provide no additional utility beyond demographic and genetic factorsSemantic proximity Read ↗

Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.Semantic proximity Read ↗

APOE modifies the association between Aβ load and cognition in cognitively normal older adults.Semantic proximity Read ↗

APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging.Semantic proximity Read ↗

APOE Genotype Modifies the Predictive Performance of Plasma Biomarkers for Amyloid Plaque Burden in Subjective Cognitive Decline.Semantic proximity Read ↗

Incident cognitive impairment: longitudinal changes in molecular, structural and cognitive biomarkersSemantic proximity Read ↗

Brain Amyloid Deposition and Longitudinal Cognitive Decline in Nondemented Older Subjects: Results from a Multi-Ethnic Population.Semantic proximity Read ↗

Utility of an Alzheimer’s Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer’s Disease: A Prospective Longitudinal StudySemantic proximity Read ↗

Influence of amyloid and APOE on cognitive performance in a late middle-aged cohort.Semantic proximity Read ↗

Cortical β-amyloid burden, gray matter, and memory in adults at varying APOE ε4 risk for Alzheimer's disease.Semantic proximity Read ↗

Associations of Amyloid, Tau, and Neurodegeneration Biomarker Profiles With Rates of Memory Decline Among Individuals Without DementiaSemantic proximity Read ↗

Progression of cerebral amyloid load is associated with the apolipoprotein E ε4 genotype in Alzheimer's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.